Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Financial Position

v3.23.1
Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current:    
Cash and cash equivalents $ 12,449 $ 37,226
Restricted cash 439 473
Accounts receivable, net 2,252 2,222
Prepaids, deposits and other receivables 2,708 5,064
Inventories, net 8,399 15,408
Total current assets 26,247 60,393
Investment – Cansativa 5,679 1,458
Property, plant and equipment, net of accumulated depreciation of $7,120 and $5,702 for the years ended December 31, 2022 and 2021, respectively 15,463 30,932
Intangible assets, net 3,354 23,117
Operating lease right-of-use assets, net 1,303  
Other non-current assets 52 260
Total Assets 52,098 116,160
Current:    
Accounts payable 2,299 3,981
Accrued expense and other current liabilities 4,238 2,898
Convertible note due 2024, current portion   16,559
Loans and borrowings, current portion 465 949
Warrant liability 113 2,205
Operating lease liabilities, current portion 1,239
Deferred revenue 1,072 653
Total current liabilities 9,426 27,245
Convertible note due 2024   1,140
Loans and borrowings 1,065 6,447
Deferred revenue   1,548
Operating lease liabilities – long-term 1,087  
Deferred tax liabilities   6,650
Other long-term liabilities 112 360
Total Liabilities 11,690 43,390
Contingencies and commitments
Shareholders’ equity    
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of December 31, 2022 and 2021
Common shares, without par value, unlimited shares authorized: 43,636,783 and 26,605,797 shares issued and outstanding as of December 31, 2022 and 2021, respectively
Additional paid-in capital 221,313 187,510
Accumulated deficit (180,905) (114,740)
Total shareholders’ equity 40,408 72,770
Total liabilities and shareholders’ equity $ 52,098 $ 116,160